Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM352195'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM352195 (US9802920, Compound I-19 | [5-Amino-1-(4-phenoxy- ...) Show SMILES Nc1c(cnn1-c1ccc(Oc2ccccc2)cc1)C(=O)c1cc2ccc(CN3CCOCC3)cc2[nH]1 Show InChI InChI=1S/C29H27N5O3/c30-29-25(18-31-34(29)22-8-10-24(11-9-22)37-23-4-2-1-3-5-23)28(35)27-17-21-7-6-20(16-26(21)32-27)19-33-12-14-36-15-13-33/h1-11,16-18,32H,12-15,19,30H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.5	n/a	n/a	n/a	n/a	n/a	n/a
Hoffman-La Roche Inc.; Chugai Pharamceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Flouresence...				US Patent US9802920 (2017) BindingDB Entry DOI: 10.7270/Q29G5PXH
					More data for this Ligand-Target Pair